|
PPP1R2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.5737499999946E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.14280000002221E-06 |
| Normal-vs-Stage2 |
5.313600E-02 |
| Normal-vs-Stage3 |
3.762700E-03 |
| Normal-vs-Stage4 |
3.110400E-02 |
| Stage1-vs-Stage2 |
3.661000E-01 |
| Stage1-vs-Stage3 |
2.861800E-01 |
| Stage1-vs-Stage4 |
1.730420E-01 |
| Stage2-vs-Stage3 |
8.899600E-01 |
| Stage2-vs-Stage4 |
8.763400E-01 |
| Stage3-vs-Stage4 |
7.320200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.81079999999456E-05 |
| Normal-vs-AfricanAmerican |
3.104500E-03 |
| Normal-vs-Asian |
4.758800E-03 |
| Caucasian-vs-AfricanAmerican |
1.956640E-01 |
| Caucasian-vs-Asian |
6.956600E-01 |
| AfricanAmerican-vs-Asian |
3.850600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.321450E-03 |
| Normal-vs-Female |
1.5771999999914E-05 |
| Male-vs-Female |
4.231600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.38379999997862E-06 |
| Normal-vs-Age(41-60Yrs) |
3.082600E-03 |
| Normal-vs-Age(61-80Yrs) |
1.403240E-03 |
| Normal-vs-Age(81-100Yrs) |
2.455400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.008000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.960400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.741400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.509200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.613600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.152200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.511800E-02 |
| Classical-VS-Follicular |
5.479400E-01 |
| Classical-VS-Other |
6.534200E-01 |
| Classical-VS-Normal |
1.29319999997435E-06 |
| Tall-VS-Follicular |
2.079800E-01 |
| Tall-VS-Other |
6.672600E-01 |
| Tall-VS-Normal |
1.461020E-01 |
| Follicular-VS-Other |
8.295000E-01 |
| Follicular-VS-Normal |
3.984700E-03 |
| Other-VS-Normal |
1.801640E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.638700E-04 |
| Normal-vs-N1 |
7.802000E-02 |
| N0-vs-N1 |
2.962600E-01 |
|
|
